Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis

Area of Science:

• Neuroscience
• Immunology
• Metabolic pathways

Background:

• Progressive multiple sclerosis (MS) lacks effective treatments, unlike relapsing-remitting MS.
• Pathogenesis of progressive MS involves mitochondrial dysfunction, neuroinflammation (microglia, astrocytes), oxidative stress, and impaired remyelination.
• Current understanding of progressive MS mechanisms is limited, hindering therapeutic development.

Purpose of the Study:

• To review experimental therapies for progressive MS.
• To explore approaches supporting neuronal and glial metabolism.
• To investigate strategies promoting remyelination.

Main Methods:

• Literature review of experimental therapies for progressive multiple sclerosis.
• Analysis of metabolic pathways and remyelination processes relevant to MS.
• Evaluation of potential therapeutic targets including mitochondrial function and glial support.

Main Results:

• Experimental therapies targeting neuronal/glial metabolism and remyelination show promise.
• Interventions may counteract energy deficits and support myelin repair.
• Standalone therapies might be limited by interconnected metabolic pathways.

Conclusions:

• A multifaceted therapeutic strategy is likely necessary for progressive MS.
• Supporting cellular metabolism and promoting remyelination are key areas for intervention.
• Experimental approaches reviewed offer potential to delay or mitigate progressive MS.